MetLife, Inc.
98.82USD
-4.7500 (-4.59%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MET.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.77▲ | $2.53 | 8 | 0 |
| Next quarter | $2.62▲ | $2.57 | 4 | 2 |
| Current year | $10.22▲ | $9.85 | 9 | 0 |
| Next year | $11.16▲ | $10.99 | 4 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.29 | $2.43 | +0.14 (+6.2%) |
| 2026-03-31 | $2.27 | $2.42 | +0.15 (+6.6%) |
| 2025-12-31 | $2.34 | $2.49 | +0.15 (+6.3%) |
| 2025-09-30 | $2.32 | $2.37 | +0.05 (+2.2%) |
296 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $110 $114 | Oct 21, 2026 |
| JP Morgan | Maintained | Overweight | $108 $110 | Oct 15, 2026 |
| Wells Fargo | Maintained | Overweight | $109 $110 | Oct 12, 2026 |
| Mizuho | Maintained | Outperform | $112 $109 | Oct 7, 2026 |
| Barclays | Maintained | Overweight | $97 $111 | Oct 7, 2026 |
| UBS | Maintained | Buy | $105 $110 | Oct 6, 2026 |
| TD Cowen | Maintained | Buy | $105 $110 | Oct 5, 2026 |
| Piper Sandler | Upgraded from Neutral | Overweight | $99 $110 | Sep 22, 2026 |
| Morgan Stanley | Maintained | Overweight | $103 $111 | Aug 24, 2026 |
| Wells Fargo | Maintained | Overweight | $101 $109 | Aug 19, 2026 |
| JP Morgan | Maintained | Overweight | $106 $108 | Aug 11, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $105 $108 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | $94 $97 | Aug 6, 2026 |
| TD Cowen | Maintained | Buy | $87 $105 | Jul 22, 2026 |
| JP Morgan | Maintained | Overweight | $96 $106 | Jul 21, 2026 |
| Evercore ISI Group | Maintained | In-Line | $96 $103 | Jul 13, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $98 $105 | Jul 13, 2026 |
| Jefferies | Maintained | Buy | $97 $103 | Jul 10, 2026 |
| Wells Fargo | Maintained | Overweight | $95 $101 | Jul 9, 2026 |
| Mizuho | Maintained | Outperform | $95 $102 | Jul 9, 2026 |
| UBS | Maintained | Buy | $102 $105 | Jul 8, 2026 |
| Barclays | Maintained | Overweight | $93 $94 | Jul 7, 2026 |
| Morgan Stanley | Maintained | Overweight | $93 $103 | Jul 6, 2026 |
| Piper Sandler | Maintained | Neutral | $86 $90 | Jun 24, 2026 |
| Piper Sandler | Maintained | Neutral | $81 $86 | May 26, 2026 |
173 filings from 33 insiders · 40 buy / 1 sell over 6m
Officers and directors of MET, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Mumenthaler Christian StephaneDirector | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| Hay Laura JDirector | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| Seitz MichelleDirector | Grant | 544 | — | — | Oct 1, 2026 |
| WEINBERGER MARK ADirector | Grant | 544 | — | — | Oct 1, 2026 |
| MCKENZIE DIANADirector | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| Johnson Jeh C.Director | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| Harris Carla ADirector | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| Glaser Daniel SDirector | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| HUBBARD ROBERT GLENNDirector | Grant | 941 | $94.35 | $89k | Oct 1, 2026 |
| Kennard William EDirector | Grant | 544 | $94.35 | $51k | Oct 1, 2026 |
| Mumenthaler Christian StephaneDirector | Grant | 21 | $95.50 | $2k | Sep 8, 2026 |
| Hay Laura JDirector | Grant | 39 | $95.50 | $4k | Sep 8, 2026 |
| MCKENZIE DIANADirector | Grant | 157 | $95.50 | $15k | Sep 8, 2026 |
| TADROS RAMYOfficer, President, U.S. Business | Grant | 115 | $95.50 | $11k | Sep 8, 2026 |
| Johnson Jeh C.Director | Grant | 59 | $95.50 | $6k | Sep 8, 2026 |
| Harris Carla ADirector | Grant | 42 | $95.50 | $4k | Sep 8, 2026 |
| Glaser Daniel SDirector | Grant | 10 | $95.50 | $955 | Sep 8, 2026 |
| HUBBARD ROBERT GLENNDirector | Grant | 618 | $95.50 | $59k | Sep 8, 2026 |
| Kennard William EDirector | Grant | 294 | $95.50 | $28k | Sep 8, 2026 |
| PAPPAS BILLOfficer, EVP, Global Tech. & Ops. | Tax | 4.0k | $95.17 | $384k | Aug 31, 2026 |
No analyst notes on MET yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 8 | 4 | 0 | 1 | Buy2.11 |
| 1 mo ago | 5 | 8 | 4 | 0 | 1 | Buy2.11 |
| 2 mo ago | 4 | 8 | 5 | 0 | 1 | Buy2.22 |
| 3 mo ago | 4 | 8 | 5 | 0 | 1 | Buy2.22 |
Members whose judged calls on MET have played out most reliably.
No settled calls on MET yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice